Abstract |
Unbalanced protein homeostasis (proteostasis) networks are frequently linked to tumorigenesis, making cancer cells more susceptible to treatments that target proteostasis regulators. Proteasome inhibition is the first licensed proteostasis-targeting therapeutic strategy, and has been proven effective in hematological malignancy patients. However, drug resistance almost inevitably develops, pressing for a better understanding of the mechanisms that preserve proteostasis in tumor cells. Here we report that CD317, a tumor-targeting antigen with a unique topology, was upregulated in hematological malignancies and preserved proteostasis and cell viability in response to proteasome inhibitors (PIs). Knocking down CD317 lowered Ca2+ levels in the endoplasmic reticulum (ER), promoting PIs-induced proteostasis failure and cell death. Mechanistically, CD317 interacted with calnexin (CNX), an ER chaperone protein that limits calcium refilling via the Ca2+ pump SERCA, thereby subjecting CNX to RACK1-mediated autophagic degradation. As a result, CD317 decreased the level of CNX protein, coordinating Ca2+ uptake and thus favoring protein folding and quality control in the ER lumen. Our findings reveal a previously unrecognized role of CD317 in proteostasis control and imply that CD317 could be a promising target for resolving PIs resistance in the clinic.
|
Authors | Jian Cheng, Guizhong Zhang, Tian Deng, Zhao Liu, Mengqi Zhang, Pengchao Zhang, Funmilayo O Adeshakin, Xiangyun Niu, Dehong Yan, Xiaochun Wan, Guang Yu |
Journal | Cell death & disease
(Cell Death Dis)
Vol. 14
Issue 5
Pg. 333
(05 20 2023)
ISSN: 2041-4889 [Electronic] England |
PMID | 37210387
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2023. The Author(s). |
Chemical References |
- Calnexin
- Molecular Chaperones
- Neoplasm Proteins
- Proteasome Inhibitors
- RACK1 protein, human
- Receptors for Activated C Kinase
- BST2 protein, human
- Bone Marrow Stromal Antigen 2
|
Topics |
- Humans
- Calnexin
(metabolism)
- Cell Survival
- Molecular Chaperones
(metabolism)
- Neoplasm Proteins
(genetics, metabolism)
- Proteasome Inhibitors
(pharmacology)
- Proteostasis
- Receptors for Activated C Kinase
(genetics, metabolism)
- Bone Marrow Stromal Antigen 2
(genetics, metabolism)
|